Home/Pipeline/Budesonide capsules, 3mg

Budesonide capsules, 3mg

Crohn's Disease

ApprovedActive

Key Facts

Indication
Crohn's Disease
Phase
Approved
Status
Active
Company

About Sciecure Pharma

Sciecure Pharma is a private, commercial-stage generic drug company that has successfully navigated the FDA approval pathway for at least two products since its founding in 2015. The company operates in the highly competitive but essential generic pharmaceuticals sector, aiming to offer lower-cost alternatives to branded medications. Its approved products include a generic version of Paroxetine HCl Extended Release tablets and Budesonide capsules, indicating a focus on central nervous system and gastrointestinal/inflammatory conditions. As a small, private entity, its growth will depend on its ability to expand its portfolio through additional ANDA filings and approvals.

View full company profile

Other Crohn's Disease Drugs

DrugCompanyPhase
PALI-2108Palisade BioPreclinical
TRX319Tr1XPhase 1/2a
Program not namedReponexPre-clinical
EXL01Exeliom BiosciencesPhase 2
CVT12011965CVasTheraPre-clinical
StroMel™ (Planned)Akan BiosciencesPlanned
omilancorNImmune BiopharmaPhase 2
Obefazimod (ABX464)AbivaxPhase 3
Icotrokinra (JNJ-2113)Protagonist TherapeuticsPhase 2/3
VTX002Ventyx BiosciencesPhase 2